UPDATE 2-BioNTech halts mRNA colorectal cancer vaccine trial after review

* Separate trial for pancreatic cancer patients is unaffected * U.S.-listed shares fall 7% * Setback follows recent trial success for Merck-Moderna's mRNA cancer vaccine (Adds details from statement,

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)